Benign Prostatic Hyperplasia: Current Treatment Strategies
February 2nd 2009Benign prostatic hyperplasia (BPH)-histologically defined as stromal and epithelial hyperplasia beginning in the periurethral transitional zone of the prostate-affects up to 80% of 80-year-old men.[1,2] With progressive prostatic enlargement, bladder outlet obstruction can result. Although the exact mechanism is unknown, lower urinary tract symptoms (LUTS) can signal progressive BPH.
Penicillin- and Carbapenem-Induced Neurotoxicity: How to Reduce the Risk
February 2nd 2009Penicillin-induced neurotoxicity was first recognized by Johnson and Walker in 1945 after intraventricular administration of benzylpenicillin.1,2 Subsequently, the β-lactams have been shown to have a higher rate of CNS effects than other classes of antibiotics.3,4
Hypertension Control Gains, Costs Climb
January 6th 2009Hypertension affects approximately 73.6 million persons in the United States or one-third of the adult population. This is an increase from 72 million persons in 2007, 65 million persons in 2002, and 50 million US adults in 1994 (or one-third, 29%, and 25% of the adult population, respectively).
Inside the Southeast Michigan ePrescribing Initiative
January 6th 2009Despite clear evidence of its benefits, widespread adoption of electronic prescribing (ePrescribing) has been slow. The vast majority of prescriptions are still written by hand, a process plagued with errors and inefficiencies. The Southeast Michigan ePrescribing Initiative (SEMI), a collaborative effort of employers, health plans, physician groups, and others, was launched in 2005 to speed the adoption of ePrescribing. SEMI has accomplished much in 4 years, enrolling more than 3000 physicians who have transmitted nearly 9.5 million electronic prescriptions while improving patient safety and winning over physicians. (Drug Benefit Trends. 2009;21:23-26)
Vaccination Recommendations for the 2008-2009 Influenza Season
January 6th 2009Influenza develops in about 20% of the global population each year. In the United States, annual influenza epidemics typically occur between late December and early March. While influenza may affect persons of any age, infection rates are highest among children.
Daschle to Assume Dual Health Policy Roles
January 5th 2009Former Senate Majority Leader Thomas A. Daschle (D, SD) will become the nation’s health care policy czar with enormous influence on health care policy and reform. In addition to being named secretary of the vast 65,000-employee Department of Health & Human Services (HHS)-home of the FDA, the Centers for Medicare & Medicaid Services (CMS), and the NIH-
Word-of-Mouth, Physician Referrals Drive Primary Care Physician, Specialist Choices
January 5th 2009Most US adults still rely on word-of-mouth and physician recommendations when selecting health care providers despite an increase in health care price and quality transparency initiatives, according to findings of a study by the Center for Studying Health System Change (HSC) released on December 4. HSC interviewed 13,500 adults for its nationally representative 2007 Health Tracking Household Survey. The study was funded by the California HealthCare Foundation.
Drug-induced lung diseases: A state-of-the-art review
January 2nd 2009p>Drug-induced lung disease (DILD) can be caused by a variety of agents, including chemotherapeutic drugs, antiarrhythmic agents, antibiotics, and NSAIDs. The clinical syndromes associated with DILD include alveolar hypoventilation, acute bronchospasm, organizing pneumonia, and hypersensitivity reactions. Amiodarone lung toxicity often manifests as a chronic fibrosing alveolitis, characterized by an insidious onset of cough, dyspnea, and weight loss. Important components of the workup include chest radiography, pulmonary function testing, and bronchoscopy with bronchoalveolar lavage (BAL). BAL is particularly helpful in identifying eosinophilic pneumonia and diffuse alveolar hemorrhage and in ruling out infectious causes. Management includes drug withdrawal and, in some cases, corticosteroid therapy. Before starting corticosteroids, it is important to rule out infectious causes of lung disease, particularly in patients receiving chemotherapy. (J Respir Dis. 2009;30(1))